MA46993A - Trousse de départ pour titrage de taux de base - Google Patents

Trousse de départ pour titrage de taux de base

Info

Publication number
MA46993A
MA46993A MA046993A MA46993A MA46993A MA 46993 A MA46993 A MA 46993A MA 046993 A MA046993 A MA 046993A MA 46993 A MA46993 A MA 46993A MA 46993 A MA46993 A MA 46993A
Authority
MA
Morocco
Prior art keywords
titting
basic rate
starter kit
starter
kit
Prior art date
Application number
MA046993A
Other languages
English (en)
Inventor
Tinna Björk Aradóttir
Henrik Bengtsson
Orden Brad Warren Van
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA46993A publication Critical patent/MA46993A/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
MA046993A 2016-11-29 2017-11-28 Trousse de départ pour titrage de taux de base MA46993A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662427333P 2016-11-29 2016-11-29
EP17151561 2017-01-16

Publications (1)

Publication Number Publication Date
MA46993A true MA46993A (fr) 2019-10-09

Family

ID=60915470

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046993A MA46993A (fr) 2016-11-29 2017-11-28 Trousse de départ pour titrage de taux de base

Country Status (5)

Country Link
US (1) US11195607B2 (fr)
EP (1) EP3549133B1 (fr)
JP (1) JP7195254B2 (fr)
CN (1) CN110012675B (fr)
MA (1) MA46993A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109863560B (zh) 2016-08-25 2023-11-17 诺和诺德股份有限公司 基础胰岛素滴定的起始工具包
WO2020023473A1 (fr) * 2018-07-26 2020-01-30 Sanofi Procédé de réglage de doses de médicament
CN114728134A (zh) 2019-09-25 2022-07-08 杨森制药公司 药物施用系统的互连
KR20220069978A (ko) * 2019-09-25 2022-05-27 얀센 파마슈티칼즈, 인코포레이티드 외부 시스템 및/또는 기타 장치들과 통신하는 약물 투여 장치
US20230037068A1 (en) * 2019-10-11 2023-02-02 Bigfoot Biomeical, Inc. Adjusting insulin therapy setting based on variability of blood glucose values
WO2021097007A1 (fr) * 2019-11-13 2021-05-20 West Pharmaceutical Services Inc. Systèmes et procédés de gestion d'utilisation de dispositif médical
WO2021113859A1 (fr) * 2019-12-03 2021-06-10 Bigfoot Biomedical, Inc. Détermination du fait que des ajustements de recommandations d'insulinothérapie sont pris en compte
CN111474293B (zh) * 2020-04-27 2023-05-05 广东博创佳禾科技有限公司 一种青枯病菌溶液测定方法及测定系统
CN116762136A (zh) * 2021-02-03 2023-09-15 德克斯康公司 基于风险的胰岛素输送转换的系统和方法
WO2022234032A2 (fr) * 2021-05-05 2022-11-10 Novo Nordisk A/S Méthodes et systèmes d'estimation de valeurs de glucose à jeun
WO2023144364A1 (fr) 2022-01-31 2023-08-03 Novo Nordisk A/S Systèmes et procédés de titrage d'insuline personnalisé
US20230330336A1 (en) * 2022-04-18 2023-10-19 Luna Health, Inc. Systems, devices and related methods of coordinating insulin management and delivery modes in fasting & non-fasting periods
WO2023212007A1 (fr) * 2022-04-26 2023-11-02 Dexcom, Inc. Système et procédé de titrage de doses d'insuline basale
WO2024178261A1 (fr) * 2023-02-24 2024-08-29 University Of Virginia Patent Foundation Système, méthode et support lisible par ordinateur pour un contrôle d'adaptation bio-comportementale adaptative (abc) dans le diabète

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004024699A (ja) 2002-06-27 2004-01-29 Asahi Medical Co Ltd 血糖管理システム、血糖管理プログラム、装着システムおよび血糖管理方法
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
US7651845B2 (en) 2004-05-13 2010-01-26 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
JP2006163489A (ja) * 2004-12-02 2006-06-22 Ntt Data Corp 発症確率算出装置、および、プログラム
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
GB2436873A (en) 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems
JP4918285B2 (ja) 2006-05-24 2012-04-18 シスメックス株式会社 生体器官の機能のシミュレーションシステム及びそのプログラム
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
US9056165B2 (en) 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
AU2007308804A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US9833184B2 (en) 2006-10-27 2017-12-05 Adidas Ag Identification of emotional states using physiological responses
EP2171630A1 (fr) 2007-06-27 2010-04-07 F. Hoffmann-Roche AG Système et procédé pour développer des thérapies spécifiques à un patient fondées sur une modélisation de la physiologie du patient
US20100262434A1 (en) * 2007-12-13 2010-10-14 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
ES2670793T3 (es) 2008-04-04 2018-06-01 Hygieia, Inc. Aparato para optimizar un régimen posológico de insulina para un paciente
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US8992464B2 (en) 2008-11-11 2015-03-31 Hygieia, Inc. Apparatus and system for diabetes management
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
WO2010072386A2 (fr) 2008-12-23 2010-07-01 Roche Diagnostics Gmbh Procédé de tests structurés de diagnostic ou d'aide à la thérapie pour un patient atteint d'une affection chronique, et dispositifs à cet effet
BRPI1008836B8 (pt) 2009-02-04 2021-06-22 Sanofi Aventis Deutschland dispositivo e método médicos para proporcionar informações de controle glicêmico
WO2010098927A1 (fr) 2009-02-27 2010-09-02 Lifescan, Inc. Module médical pour stylo de distribution de médicaments
US20100280334A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Patient state detection based on support vector machine based algorithm
JP5538749B2 (ja) * 2009-06-03 2014-07-02 キヤノン株式会社 診断支援システム及びその診断支援方法、プログラム
JP5830466B2 (ja) 2009-09-02 2015-12-09 ユニバーシティ オブ ヴァージニア パテント ファウンデーション 所定の将来の期間内における患者の低血糖現象の発生の可能性を観測するための方法、そのためのシステム及びそのためのコンピュータで実行させるためのプログラム
US8771251B2 (en) 2009-12-17 2014-07-08 Hospira, Inc. Systems and methods for managing and delivering patient therapy through electronic drug delivery systems
US9457145B2 (en) 2010-01-20 2016-10-04 Roche Diabetes Care, Inc. Method and device for improving glycemic control
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US10010273B2 (en) 2011-03-10 2018-07-03 Abbott Diabetes Care, Inc. Multi-function analyte monitor device and methods of use
ES2703610T3 (es) 2011-12-15 2019-03-11 Becton Dickinson Co Enlace de telemetría de campo cercano para pasar un secreto compartido para establecer un enlace de comunicación de radio frecuencia seguro en un sistema de monitorización de la condición fisiológica
US10022498B2 (en) 2011-12-16 2018-07-17 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
WO2013117681A1 (fr) * 2012-02-10 2013-08-15 Alere Switzerland Gmbh Dosage et procédé de détermination de résistance à l'insuline
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9904659B1 (en) 2012-10-11 2018-02-27 Trigeminal Solutions, Inc. Technique for identifying association variables
US9901677B2 (en) * 2012-10-16 2018-02-27 Bigfoot Biomedical, Inc. Infusion pump system and methods
JP5511033B1 (ja) 2012-12-04 2014-06-04 Ｎｅｃシステムテクノロジー株式会社 血糖値予測装置、測定装置、血糖値予測方法、及びプログラム
US9092556B2 (en) 2013-03-15 2015-07-28 eagleyemed, Inc. Multi-site data sharing platform
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US11238975B2 (en) 2014-04-02 2022-02-01 University Of Louisville Research Foundation, Inc. Computer aided diagnosis system for classifying kidneys
US9724470B2 (en) 2014-06-16 2017-08-08 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
JP6989262B2 (ja) 2014-10-27 2022-01-05 アセコー インコーポレイテッド 皮下外来患者管理
US20160302671A1 (en) 2015-04-16 2016-10-20 Microsoft Technology Licensing, Llc Prediction of Health Status from Physiological Data
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10463297B2 (en) * 2015-08-21 2019-11-05 Medtronic Minimed, Inc. Personalized event detection methods and related devices and systems
US10867012B2 (en) * 2015-08-21 2020-12-15 Medtronic Minimed, Inc. Data analytics and insight delivery for the management and control of diabetes
CA3001448A1 (fr) * 2015-10-09 2017-04-13 Dianovator Ab Systemes medicaux et procede pour determiner des parametres lies a l'insulinotherapie, pour predire des valeurs de glucose et pour fournir des recommandations de dosage d'insuline
CA3024111A1 (fr) * 2016-05-13 2017-11-16 WellDoc, Inc. Gestion de base de donnees et interfaces utilisateur graphiques pour des mesures recueillies par analyse sanguine
CN109863560B (zh) * 2016-08-25 2023-11-17 诺和诺德股份有限公司 基础胰岛素滴定的起始工具包
US10854323B2 (en) * 2016-12-21 2020-12-01 Medtronic Minimed, Inc. Infusion systems and related personalized bolusing methods

Also Published As

Publication number Publication date
CN110012675A (zh) 2019-07-12
EP3549133A1 (fr) 2019-10-09
JP2020515925A (ja) 2020-05-28
CN110012675B (zh) 2024-02-27
US11195607B2 (en) 2021-12-07
US20190272912A1 (en) 2019-09-05
EP3549133B1 (fr) 2025-01-29
JP7195254B2 (ja) 2022-12-23

Similar Documents

Publication Publication Date Title
EP3630078A4 (fr) Agents pour chimio-embolisation
EP3296979A4 (fr) Kit de formation pour reconstuction de valvule aortique
PL3411541T3 (pl) Szalunek poziomy
PT3215530T (pt) Anticorpos de il-6 melhorados
MA50533A (fr) Imipridones pour gliomes
GB2561567B (en) Formwork base
EP3519028A4 (fr) Étrier pour harnais
EP3560902A4 (fr) Composition pour marbre artificiel
MA41116A (fr) Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif
EP3722105C0 (fr) Dispositif de roulette s'adaptant à une marche
PL3402622T3 (pl) Urządzenie do odlewania
EP3320636A4 (fr) Obscurcisseur non malléable pour fonctions rares
EP3488317A4 (fr) Partage d'écran
FR3027790B1 (fr) Base support ambidextre pour fil de suture
EP3440732A4 (fr) Additif pour électrolytes
EP3338116A4 (fr) Modèle de fracture fondé sur des mécanismes pour géo-matériaux
GB201612242D0 (en) Novel kit
EP3725860A4 (fr) Composition pour encapsulation
HUE045717T2 (hu) Berendezés beton idomrészek elõállítására
DK3470148T3 (da) Indretning til fremstilling af støbedele af metal
EP3508223A4 (fr) Composition pour activer la neurogenèse
EP3560568A4 (fr) Blocs d'assemblage
EP3481967A4 (fr) Compositions cellulaires pour la régénération tissulaire
EP3684608A4 (fr) Accessoire pour clôture
EP3554276A4 (fr) Nouvelles compositions pour le masquage du goût